Back to company

EJP PHARMACEUTICAL ApS: Financial statements 2020

CVR: 87923614

EJP PHARMACEUTICAL ApS (CVR 87923614) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -74,699 and a net result of DKK -139,663 compared with DKK 566,249 the year before. Equity amounted to DKK 6,945,640. The solvency ratio was 99.7%. The company had 1 employee in the financial year.

Gross Profit
-74,699 kr.
Profit/Loss
-139,663 kr.
Equity
6,945,640 kr.
Total Assets
6,967,175 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020--75 t.-140 t.6.9 mio.1
2019--566 t.7.6 mio.1
2018---685 t.7.1 mio.1
2017--67 t.1.3 mio.7.9 mio.0
2016--124 t.-1.6 mio.8.6 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is EJP PHARMACEUTICAL ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

EJP PHARMACEUTICAL ApS: The 2019 annual report is outMar 27, 2020

EJP PHARMACEUTICAL ApS has published its annual report for 2019. The net result was DKK 566,249.

About EJP PHARMACEUTICAL ApS

EJP PHARMACEUTICAL ApS is a Danish company of the type Anpartsselskab based in Skodsborg, founded in 1982. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Ejvind Jersie Pedersen. The company is owned by Ejvind Jersie Pedersen. The company has 1 employee. In 2025, the company reported a gross profit of DKK -28,266 and a net result of DKK 214,282 compared with DKK 414,071 the year before. Equity amounted to DKK 814,282.